139 related articles for article (PubMed ID: 16982737)
21. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells.
Bueno C; Catalina P; Melen GJ; Montes R; Sánchez L; Ligero G; García-Pérez JL; Menendez P
Carcinogenesis; 2009 Sep; 30(9):1628-37. PubMed ID: 19587093
[TBL] [Abstract][Full Text] [Related]
22. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
[TBL] [Abstract][Full Text] [Related]
23. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
[TBL] [Abstract][Full Text] [Related]
24. Enzymatic active site of caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD.
Sakahira H; Takemura Y; Nagata S
Arch Biochem Biophys; 2001 Apr; 388(1):91-9. PubMed ID: 11361146
[TBL] [Abstract][Full Text] [Related]
25. Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.
Yang J; Bogni A; Cheng C; Bleibel WK; Cai X; Fan Y; Yang W; Rocha JC; Pei D; Liu W; Dolan ME; Pui CH; Relling MV
Clin Pharmacol Ther; 2008 Dec; 84(6):691-7. PubMed ID: 18509329
[TBL] [Abstract][Full Text] [Related]
26. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
RamaChandran S; Ariffin H
Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
Nanya M; Sato M; Tanimoto K; Tozuka M; Mizutani S; Takagi M
PLoS One; 2015; 10(12):e0144540. PubMed ID: 26657054
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial anchoring of PKCalpha by PICK1 confers resistance to etoposide-induced apoptosis.
Wang WL; Yeh SF; Huang EY; Lu YL; Wang CF; Huang CY; Lin WJ
Apoptosis; 2007 Oct; 12(10):1857-71. PubMed ID: 17610064
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements.
Kantidze OL; Razin SV
Gene; 2007 Apr; 391(1-2):76-9. PubMed ID: 17234368
[TBL] [Abstract][Full Text] [Related]
30. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
[TBL] [Abstract][Full Text] [Related]
31. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II.
Treszezamsky AD; Kachnic LA; Feng Z; Zhang J; Tokadjian C; Powell SN
Cancer Res; 2007 Aug; 67(15):7078-81. PubMed ID: 17671173
[TBL] [Abstract][Full Text] [Related]
32. The major apoptotic endonuclease DFF40/CAD is a deoxyribose-specific and double-strand-specific enzyme.
Hanus J; Kalinowska-Herok M; Widlak P
Apoptosis; 2008 Mar; 13(3):377-82. PubMed ID: 18283539
[TBL] [Abstract][Full Text] [Related]
33. Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis.
Sim SP; Liu LF
J Biol Chem; 2001 Aug; 276(34):31590-5. PubMed ID: 11406628
[TBL] [Abstract][Full Text] [Related]
34. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV
J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974
[TBL] [Abstract][Full Text] [Related]
35. Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34
Harada Y; Shingai N; Ding Y; Sadato D; Hayashi Y; Yamaguchi M; Okuyama Y; Shimoyama T; Ohashi K; Harada H
Cancer Sci; 2020 May; 111(5):1851-1855. PubMed ID: 32216001
[TBL] [Abstract][Full Text] [Related]
36. Differential DNases are selectively used in neuronal apoptosis depending on the differentiation state.
Shiokawa D; Tanuma S
Cell Death Differ; 2004 Oct; 11(10):1112-20. PubMed ID: 15167901
[TBL] [Abstract][Full Text] [Related]
37. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
[TBL] [Abstract][Full Text] [Related]
38. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions.
Cerveira N; Micci F; Santos J; Pinheiro M; Correia C; Lisboa S; Bizarro S; Norton L; Glomstein A; Asberg AE; Heim S; Teixeira MR
Haematologica; 2008 Jul; 93(7):1076-80. PubMed ID: 18492691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
